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Interleukin-2 (E-2) gene regulation was investigated in primary cultures 
of highly purified human peripheral blood CD28+T cells. Two discrete 
mechanisms for induction of T-cell proliferation could be distinguished by 
examining cell cycle progression and the expression of the IL-2 gene. 
Stimulation of cells by CD3 MoAb induced only transiently expressed, 
small amounts of IL-2 mRNA that was completely suppressed by cyclo- 
sporine. Costimulation of T cells with CD3 MoAb and either CD28 MoAb or 
PMA, but not calcium ionophore, induced a 50-lOO-fold increased ln IL-2 
gene expression and secretion. High levels of IL-2 gene expression could 
also be achieved by stimulation with calcium ionophore and PMA or CD28 
MoAb and PMA, but not by CD28 MoAb plus calcium ionophore. IL-2 gene 
expression and T-cell prollferatlon induced by CD3 MoAb plus PMA or 
calcium ionophore plus PMA were completely suppressible by cyclo- 
sporlne. In contrast, IL-2 gene expression and T-cell proliferation induced 
by CD28 MoAb plus PMA were unaffected by cyclosporine. The CD28 sig- 
nal was dependent on new protein synthesis. Nuclear run-on transcription 
assays showed that anti-CD28 did not affect lymphoklne transcription. A 
major effect of CD28 stimulation on mRNA stabiity was shown by studies 
using actinomycin D, CD28 stimulation substantially increased the half- 
life of IL-2 and TNP-alpha mRNA. The effects of anti-CD28 stlmulation 
were specific for growth factors, and thus differ from previously described 
effects of cyclohexlmlde on mRNA stability. These studies suggest the exis- 
tence of two biochemical pathways for the induction of IL-2 production, 
one that occurs at the transcriptional level and is mediated by intracellular 
calcium release and protein ldnase C and is cyclosporlne-sensitive, and one 
that acts post-transcriptionally, is mediated by CD28 stimulation, and is 
cyclosporine-resistant. 
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Introduction 
Interleukin-2 (IL-2) is a lymphocyte growth factor that is required for T cells to 
progress from G, into S phase of the cell cycle [ 11. According to the current 
paradigm, the messages provided by increased intracellular ionized calcium and 
protein kinase C activation result in IL-2 gene activation [24]. Ligation of the T-cell 
antigen receptor and the associated CD3 complex, either by antigen or by mono- 
clonal antibodies (MoAb), has been shown to cause both activation of protein kinase 
C and elevation of intracellular calcium [S, 61. However, there is accumulating 
evidence that stimulation of the CD28 antigen can activate resting T cells to prolifer- 
ate via mechanisms that are distinct from the cytoplasmic messages generated after 
stimulation of the CD3 molecular complex. 
In the present report we present evidence to suggest the existence of two dis- 
tinct mechanisms of IL-2 gene regulation in peripheral blood T cells. Only small 
amounts of IL-2 mRNA were expressed after stimulation of cells by CD3, and in 
accord with previous studies [7-91, IL-2 production after CD3 stimulation was 
entirely prevented by cyclosporine. Direct elevation of intracellular calcium and 
activation of protein kinase C by calcium ionophore plus phorbol ester treatment 
resulted in T-cell proliferation and IL-2 mRNA expression that was completely 
suppressed by cyclosporine. Similarly, proliferation after CD3 plus phorbol ester 
stimulation was prevented by cyclosporine. In contrast, proliferation induced by 
the CD28 pathway was found to be entirely resistant to cyclosporine, and further- 
more, it was demonstrated that CD28induced IL-2 expression is resistant to cyclo- 
sporine. Nuclear run-on transcription studies indicate that the mechanism of the 
CD28 signal is post-transcriptional and involves stabilization of lymphokine 
mRNA. 
Materials and methods 
Monoclonal antibodies 
CD28 MoAb 9.3 (IgG2a) was purified on protein A-Sepharose, dialysed against 
phosphate-buffered saline, filtered through a 0.22 urn sterile filter, and cleared of 
aggregates by centrifugation (100,000 xg for 45 min) prior to use in functional 
assays [IO]. 
Cells 
Peripheral blood lymphocytes (-2.5 x 109) were isolated from buffy coats 
obtained by leukopheresis of healthy donors aged 21 to 31 years using density 
gradient centrifugation. The CD28+ subset of T cells was then isolated from 
the PBL by negative selection using immunoabsorption as previously described 
1101. 
Proliferation assays 
Cells were cultured in quadruplicate samples in flat-bottom, 96-well microtitre 
plates at 5 x lo4 cells per well in RPM1 medium containing 5% heat-inactivated 
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fetal calf serum (Hyclone, Logan UT). Cell proliferation was measured in a liquid 
scintillation counter after pulsing cells for the last 6-8 h of 3 d cultures with 
1 uCi/ well of 3H-thymidine (New England Nuclear Corp., Boston, MA, USA). 
Cell cycle analysis 
Cells were analysed for DNA content on an Ortho Cytofluorograph after staining 
with propidium iodide using a procedure described by Krishan [ 111. The distri- 
bution of cells within the cell cycle was determined by the method of Dean and Jett 
[la 
Uridine incorporation 
Incorporation of 3H-uridine (5-6-3H uridine 47 Ci/mmol, New England Nuclear) 
was used as a measure of total cellular RNA synthesis and of G, to G, cell cycle 
transition. Cells (1 x 105/well) were cultured for various durations and pulsed for the 
last 6 h with 1 &i/well of tritiated uridine, and uridine incorporation determined on 
a liquid scintillation counter after the cells were collected on glass fibre filters. 
RNA (Northern) blot analysis 
CD28+ T cells were cultured at 2 x 106/ml in complete medium. The cells were 
harvested by centrifugation and total cellular RNA extracted using guanidinium 
isothiocyanate. The samples were equalized for rRNA, and the equalization con- 
firmed by ethidium bromide staining of equal amounts of the RNA samples 
separated on a non-denaturing 1 y0 agarose gel as described previously [lo]. 
DNA probes 
The 32P probes used in these experiments were all the result of nick translation of 
gene-specific inserts (50 to 100 ng) isolated from low-melt agarose gels following 
digestion of the plasmid in which they were propagated with appropriate restriction 
endonucleases. The IL-2 specific probe is a 1 .O kb Pst I cDNA insert derived from 
the pTCGF5 plasmid obtained from S Arya [ 131. The HLA B7 probe was a 1.4 kb 
Pst I fragment isolated from pHLA-B7 [ 141. 
Lymphokine assays 
IL-2 was measured by adding four five-fold dilutions of culture supernatants to 
quadruplicate wells containing 8 x lo3 cells of the IL-2 dependent cell line 
CTLL-2 (American Type Tissue Collection, Rockville MD, USA [ 151). Thymidine 
incorporation was determined after 24 h of culture and the data analysed by probit 
analysis. One unit was defined as the amount of IL-2 leading to half maximal 
proliferation. In some assays, IL-2 was measured using an ELISA (Genzyme Corp., 
Boston MA, USA). 
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Figure 1. Effects of CD28 MoAb 9.3 and CD3 MoAb G19-4 on (a) RNA and (b) DNA synthesis. 
CD28+ T cells (1 x lO’/well) were cultured in the presence of medium, PHA 10 ug/ml, PMA 1 ng/ml, 
CD28 MoAb 9.3 100 ng/ml, immobilized CD3 MoAb G19-4 200 ng/well. The cells were cultured for 
either 18 h and pulsed (a) for 6 h with 1 @/well tritiated uridine or (b) for 72 h and pulsed for 6 h with 
1 @/well with tritiated thymidine and the mean plus 1 S.E.M. cpm of quadruplicate samples determined 
by liquid scintillation counting. 
Results 
Effects of anti-CD28 and anti-CD3 stimulation on entry into the cell cycle 
Previous results indicated that stimulation of purified CD28+ T cells by anti-CD28 
MoAb alone does not result in cell cycle progression, and that the CD28 signal 
synergizes with protein kinase C activation to cause cell size increases that were 
evident by N 12 h after stimulation [lo]. Stimulation of CD4+ T cells with immobi- 
lized CD3 MoAb has been shown by Geppart et al. [ 161 to cause proliferation that is 
independent of accessory cells. In addition, they found that anti-CD28 augmented 
the rate of proliferation only after stimulation with suboptimal and not optimal 
amounts of immobilized CD3 MoAb. CD28+ T cells were cultured in medium, 
MoAb 9.3, PHA, PMA with and without MoAb 9.3, and immobilized CD3 MoAb 
with and without MoAb 9.3, and were analysed for DNA synthesis on day 3 of 
culture. In addition, companion cultures were analysed simultaneously for uridine 
incorporation as an index of total cellular RNA synthesis (Figure. 1). Similar to 
Geppart et al. [ 161, we found that immobilized CD3 MoAb was mitogenic for puri- 
fied CD28+ T cells, and that the addition of soluble anti-CD28 to cells stimulated 
with optimal amounts of CD3 MoAb did not increase proliferation. After treatment 
of purified CD28+ cells with PHA or PMA only, thymidine incorporation was only 
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slightly above baseline, indicating that these reagents are co-mitogens for T cells, and 
that for these reagents, ‘accessory’ cells (monocytes) are required to cause T-cell 
proliferation. Similarly, neither anti-CD28, PHA nor PMA alone were able to cause 
significant uridine incorporation after 24 h of culture. Under conditions associated 
with DNA synthesis (stimulation by immobilized CD3 MoAb and soluble anti- 
CD28 MoAb plus PMA), increased uridine incorporation also occurred. However, 
in contrast to the effects on thymidine incorporation, the addition of CD28 MoAb to 
cells cultured with optimal amounts of immobilized CD3 MoAb G19-4, caused an 
-two-fold augmentation in uridine incorportion over that after stimulation by CD3 
MoAb alone. 
CD28 regulates IL-2production that is rate limiting after CD3 stimulation 
Cantrell et al. demonstrated that IL-2 is a progression factor that is necessary and 
sufficient for a major subset of T cells to progress from the G, to S phase of the cell 
cycle [ 11. The results presented heretofore demonstrate that CD28 stimulation acts 
early in the cell cycle to increase total cellular RNA synthesis in conjunction with 
suboptimal to optimal amounts of CD3 stimulation, and that CD28 stimulation 
increases the rate of DNA synthesis only when CD3 stimulation is suboptimal. 
These observations are compatible with the hypothesis that IL-2 production from 
purified T cells may be rat limiting after CD3 stimulation. The next series of exper- 
iments explored whether or not the CD28 signal could regulate IL-2 production that 
might limit cell cycle progression after CD3 stimulation. 
Northern blot analysis was used to characterize the kinetics of IL-2 gene expres- 
sion after stimulation by optimal amounts of immobilized CD3 MoAb with or with- 
out CD28 stimulation. In addition, the supematants from these cultures were also 
analysed for IL-2 content and the cells analysed for cell cycle progression (data not 
shown). Since rRNA increases in direct proportion to cell volume as cells progress 
through the cell cycle, each sample was equalized for the level of rRNA to avoid the 
measurement of mRNA variations attributable only to increases in cell volume. 
Northern blots were hybridized sequentially with probes specific for IL-2, and a 
Class I HLA gene used to serve as an mRNA probe for a constitutively expressed 
gene. IL-2 mRNA expresion was suprisingly low after CD3 stimulation and peaked 
at 6 h of culture; only small amounts of IL-2 could be detected in the culture super- 
natant (5 U/ml at 24 h) although vigorous proliferation occurred as 41 o/o of cells were 
in the S phase of the cell cycle or beyond. In contrast, in cells stimulated with CD3 
plus CD28, there was a > 30-fold increase in mRNA expression that peaked at 6 h of 
culture and persisted to 24 h of culture. There was a comparable increase in IL-2 
concentration in the culture supematant ( > 200 U/ml at 48 h) from the CD3 plus 
CD28 condition although the percentage of cells in the S phase or beyond of the cell 
cycle was similar to that after CD3 stimulation. HLA Class I mRNA expression was 
not affected by CD28 stimulation. Thus, these findings show that CD28 stimulation 
both sustains and substantially augments IL-2 production and secretion in conjunc- 
tion with CD3 stimulation, and are consistent with the above results (Figure 1) that 
CD3 stimulation, resulting in only modest IL-2 expression, is sufficient for the 
entry into the first round of the cell cycle and the initiation of DNA synthesis in a 
comparable fraction of cells as occurs after stimulation by CD3 plus CD28. 
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Table 1. Kinetics of IL-Z secretion after stimulation by anti-CD3 and anti-CD28’ 
IL-2 production (U/ml) DNA synthesis (cpm x 10m3) 
Monoclonal antibody Hours of culture 
Immobilized Soluble 6 12 36 48 
CD3 G19-4 200 ng 
CD3 G19-4 200 ng 
CD3 G19-4 50 ng 
CD3 G19-4 50 ng 
CD3 G19-4 10 ng 
CD3 G19-4 10 ng 
CD3 G19-4 4 ng 
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‘CD28’ T cells (5 x lO’/well) were cultured in quadruplicate in the presence of immobilized 
CD3 MoAb at the indicated concentration in the presence or absence of MoAb 9.3 (1 pg/ml) and dilutions 
of culture supernatants analysed for IL-2 content after 6-36 h of culture and thymidine incorporation 
(mean + 1 S.E.M.) determined after 72 h of culture. 
To examine further the ability of CD28 to augment IL-2 production after CD3 
stimulation, cells were cultured with suboptimal to optimal amounts of immobi&ed 
CD3 MoAb in the presence or absence of CD28 MoAb 9.3 and the supernatants 
assayed for IL-2 concentration at 6, 12, and 36 h of culture (Table 1). There was a 
lO-lOO-fold augmentation of IL-2 secretion by cells stimulated with anti-CD28 at all 
levels of CD3 stimulation, although DNA synthesis was increased by anti-CD28 
only with conditions having suboptimal CD3 stimulation. 
CD28-induced T-cell proliferation is resistant to the eflects of cyclosporine 
One explanation for the supoptimal IL-2 gene expression after CD3 stimulation is 
that even optimal amounts of CD3 stimulation result in suboptimal calcium and 
protein kinase C signals. Alternatively, it is possible that another distinct membrane 
signal, such as that provided by CD28, is required for optimal IL-2 expression 
following cell surface stimulation by antigen. It is also possible that CD3 stimulation 
is associated with both positive and negative effects, and that the CD28 signal func- 
tions to override the negative signal so that IL-2 secretion then resembles that 
induced by calcium ionophore plus phorbol ester. To distinguish between these 
possibilities, we investigated the effects of cyclosporine on CDZS-induced activation, 
as there is evidence that one mechanism of action of cyclosporine is to prevent IL-2 
gene expression [9,17]. CD28+ T cells were cultured with immobilized CD3 MoAb 
G19-4, immobilized CD3 MoAb plus CD28 MoAb, soluble CD3 MoAb plus PMA, 
CD28 MoAb plus PMA, and ionomycin plus PMA, alone and in the presence of 
increasing amounts of cyclosporine (Table 2). The above combinations of agonists 
were chosen because previous studies had shown that CD3 MoAbs alone in solution 
are not mitogenic for purified T cells while the combination of PMA plus soluble 
CD3 or CD28 MoAbs is fully mitogenic [9, 181, and furthermore, on purified 
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Table 2. Eflects of cyclosporine on CD3 and CD28-mediated proliferation of T cells’ 
Thymidine incorporation (cpm x 10m3) 
Stimulus 0 
Cyclosporine @g/ml) 




CD3 G19-4 25.Ok3.1 15.3+_0.9 13.1kO.5 2.6f0.4 2.2f0.2 92 
CD3fCD28 9.3 30.9f2.3 21.6kO.3 15.8+0.6 ll.lf0.7 10.7f0.6 65 
CD289.3+PkiA 27.7k1.5 24.3kO.7 26.8f1.5 24.7+1.8 28.0f0.3 <o 
Exp. 2 
CD3 G19-4+PMA 35.3f3.4 4.8kO.4 2.3kO.2 ND’ ND 93 
CDA8 9*3+PMA 41.6f4.2 39.6f5.2 40.8k3.2 ND ND 2 
PMA+Ionomycin 19.7f 1.7 7.6kO.7 3.7f0.4 ND ND 81 
‘CD28-positive T cells were cultured as described in Materials and methods and thymidine incorpor- 
ation (mean k 1 S.D.) was determined on day 3 of culture. In experiment 1 the conditions tested were: 
CD3 antibody adsorbed onto plastic; antibody 9.3 100 ng/ml; and PMA 1 ng/ml; in experiment 2 the 
conditions were as above except that CD3 MoAb G19-4 was soluble at 1 pg/ml and ionomycin was 0.1 pg/ 
ml. The percentage inhibition of proliferation was calculated between cells cultured in medium only OS 
cyclosporine at 1.2 pg/ml. (exp. 1) or 0.4 pg/ml (exp. 2). Cells cultured in the absence of cyclosporine were 
given cyclosporine diluent. Thymidine incorporation of cells cultured in medium, PMA, or MoAb 9.3 
only was < 150 cpm. 
?Not done. 
T cells, soluble CD28 MoAb augments the effects of immobilized and not soluble 
CD3 MoAbs. Previous studies have shown that T-cell proliferation induced in PBL 
with soluble MoAbs to the CD3/T-cell receptor complex is sensitive to cyclosporine 
with an ID5’ of N 25 ng/ml[7-91. We confirmed those results (not shown) and found 
that proliferation induced in purified T cells by immobilized CD3 MoAb, CD3 
MoAb plus PMA, or ionomycin plus PMA was also sensitive to cyclosporine. In 
contrast, proliferation induced by the CD28 plus PMA pathway was entirely resist- 
ant to cyclosporine, even at 1.2 pg/ml (Table 2). The resistance of T cells to cyclos- 
porine after CD28 plus phorbol ester treatment was reproduced using lymphocytes 
from more than 10 different donors, indicating that the resistance to cyclosporine of 
T cells stimulated in this manner does not reflect individual variation. When cells 
were cultured with immobilized CD3 MoAb plus CD28 MoAb 9.3, an intermediate 
level of sensitivity to cyclosporine was found (Table 2). 
Distinct effects of cyclosporine on CD28 and on calcium ionophore plus phorbol 
ester-induced IL-2 mRNA expression 
Given the result that T-cell proliferation induced by CD28 stimulation may be 
partially or entirely resistant to cyclosporine, Northern blots were prepared to deter- 
mine the effects of cyclosporine on CD28-induced IL-2 mRNA expression. CD28+ 
cells were stimulated with either CD28 MoAb 9.3 plus PMA, with immobilized CD3 
MoAb G19-4+MoAb 9.3, in the presence or absence of cyclosporine (Figure. 2). 
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Figure 2. Effects of anti-CD28 stimulation on IL-2 mRNA expression, IL-2 secretion, and cell cycle 
progression. CD28+ T cells were cultured with medium (MRD), CD3 MoAb G19-4 immobilized to 
plastic, or immobilized CD3 MoAb plus CD28 MoAb 9.3 (1 ug/ml). The cells were harvested after 1,6, 
12, or 24 h of culture and total cellular RNA isolated and equalized for rRNA. The equalization was 
confirmed by ethidium bromide staining of 10% aliquots of each RNA sample separated on a non- 
denaturing 1% agarose gel (upper panel). Northern blots were hybridized sequentially with IL-2 and 
HLA Class-I-specific cDNA probes. In addition, supematants were analysed for IL-2 content by 
ELISA, and cell cycle distribution was measured after 48 h of culture by staining with propidium iodide 
and analysis by flow cytometry. 
There was full expression of IL-2 mRNA in cells cultured for 12 h with 9.3 plus 
PMA in the presence of cyclosporine at 1 ug/ml (Figure 2, left panel); previous 
results showed that the time course of IL-2 mRNA expression under these con- 
ditions was identical in cells treated with cyclosporine compared with those cultured 
in the absence of cyclosporine [lo]. Only minimal amounts of IL-2 mRNA were 
induced in CD3-stimulated cells in comparison to CD28 plus PMA-stimulated cells, 
and this induction was completely prevented by cyclosporine (Figure 2, right panel). 
The addition of soluble CD28 MoAb 9.3 to cells stimulated by immobilized CD3 
caused a marked enhancement of IL-2 mRNA expression, and in contrast to the 
CD28 plus PMA system, the IL-2 production of cells cultured with CD3 plus CD28 
MoAb 9.3 was partially inhibited by cyclosporine, although the cells stimulated with 
CD28 plus CD3 in the presence of cyclosporine had equivalent amounts of IL-2 
mRNA as cells cultured in the absence of the drug and stimulated by immobilized 
CD3 only. IL-2 mRNA expression of cells stimulated by calcium ionophore plus 
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phorbol ester was similar in magnitude to that of cells stimulated with CD28 plus 
CD3, but in contrast, was completely inhibited by cyclosporine (not shown), similar 
to cells cultured with CD3. Transcripts hybridizing with the HLA Class I gene were 
detectable at equivalent levels in all conditions tested, excluding non-specific degra- 
dation of mRNA as an explanation for the failure to detect IL-2 mRNA in the 
cyclosporine-sensitive conditions. 
Discussion 
The foregoing studies analysed the effects of CD3 and CD28 stimulation of resting T 
cells on cell cycle entry and IL-2 gene expression. Stimulation by optimal amounts of 
CD3 or by CD3 plus CD28 was found to cause equivalent levels of proliferation as 
assayed by DNA synthesis. However, there were striking differences in IL-2 
secretion. CD3 stimulation caused only small amounts of IL-2 to be produced for 
a brief duration, while CD3 plus CD28 caused substantial augmentation and pro- 
longation of total cellular RNA synthesis and IL-2 secretion. These results are the 
first example of IL-2 production within a single population of cells that may be either 
sensitive or resistant to cyclosporine, depending on the form of stimulation, and 
suggest that CD28 regulates IL-2 gene expression in a manner that differs bio- 
chemically from IL-2 expression induced after CD3 or calcium ionophore plus 
protein kinase C stimulation. In preliminary experiments (not shown), the CD28 
signal appears to regulate the stability of the lymphokine mRNA, and thus to act at a 
post-transcriptional level. In contrast, results from nuclear run-on transcription 
assays indicate that the signals provided by CD3 (calcium and protein kinase C 
activation) cause transcriptional activation of lymphokine expression, yielding 
mRNA that has a short half-life. 
In the present study we found only small amounts of IL-2 mRNA were produced 
in cultures of purified T cells stimulated with CD3, and that CD28 both prolonged 
and caused a striking augmentation of IL-2 mRNA expression in cells stimulated 
with CD3. If the barely detectable levels of IL-2 mRNA after CD3 stimulation 
indicate that IL-2 production is not rate limiting and signify that the amount of IL-2 
that is necessary for one round of cell cycle proliferation in an autocrine fashion is 
quite small, then our results suggest that the role for CD28 may be to augment IL-2 
production and to recruit cells via a paracrine as well as an autocrine mechanism. The 
function of CD28 would be to amplify and sustain a response that was initiated in an 
antigen-specific manner in z&o by up-regulation of IL-2 production. Alternatively, 
the minimal amounts of IL-2 mRNA expressed after stimulation by immobilized 
CD3 antibodies in the absence of the CD28 signal could indicate that CD3/T-cell 
receptor-induced proliferation is primarily dependent upon growth factors other 
than IL-2, such as IL-4 [19], and that the CD28 pathway regulates an IL-2 
dependent system. 
T-cell proliferation induced by CD28 plus PMA was entirely resistant to cyclo- 
sporine, in contrast to the sensitive pattern that we found for immobilized CD3 
MoAb, and that others have reported previously for soluble CD3 MoAb and the 
lectins phytohemagglutinin and concanavalin A [7-9, 201. An intermediate result 
was found with CD28 plus CD3/T-cell receptor-induced proliferation; both the 
rate of proliferation and IL-2 mRNA expression were decreased -25o/o-75o/o by 
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cyclosporine, depending on the lymphocyte donor. In addition we have found that 
CD28 stimulation confers resistance to the antiproliferative effects of glucocorticiods 
(data not shown). Thus, the CD28 pathway is able to overcome the effects of several 
distinct immunosuppressants, suggesting that the CD28 pathway may have an 
important role in viva in T-cell proliferation that is resistant to currently available 
immunosuppressants. Together, the present results suggest that the CD28 pathway 
activates a major subset of T cells to proliferate via an IL-2 dependent mechanism 
that is biochemically distinct from CD3. 
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